the in-vitro monitoring system was shown to be useful regardless of epstein-barr virus ( ebv ) status , clinical status of patients and cytogenetic anomalies ( 8 t ( 8 ; 14 ) 2 t ( 8 ; 22 ) 2 when bm was cytologically normal or suspect , i.e. , less than 5 % bl cells , the in-vitro monitoring system was shown to be more sensitive than cytological examination in 25 of 56 cases ( 44 % ) .
C0005953
bm
C0006413
bl